These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19159461)

  • 41. Contrasting effects on ganciclovir susceptibility and replicative capacity of two mutations at codon 466 of the human cytomegalovirus UL97 gene.
    Martin M; Goyette N; Boivin G
    J Clin Virol; 2010 Dec; 49(4):296-8. PubMed ID: 20843736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency.
    Prichard MN; Gao N; Jairath S; Mulamba G; Krosky P; Coen DM; Parker BO; Pari GS
    J Virol; 1999 Jul; 73(7):5663-70. PubMed ID: 10364316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiviral activity of maribavir in combination with other drugs active against human cytomegalovirus.
    Chou S; Ercolani RJ; Derakhchan K
    Antiviral Res; 2018 Sep; 157():128-133. PubMed ID: 30040968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between autophosphorylation and phosphorylation of exogenous substrates by the human cytomegalovirus UL97 protein kinase.
    Baek MC; Krosky PM; Coen DM
    J Virol; 2002 Dec; 76(23):11943-52. PubMed ID: 12414936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The UL97 gene product of human cytomegalovirus is an early-late protein with a nuclear localization but is not a nucleoside kinase.
    Michel D; Pavić I; Zimmermann A; Haupt E; Wunderlich K; Heuschmid M; Mertens T
    J Virol; 1996 Sep; 70(9):6340-6. PubMed ID: 8709262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistance to maribavir is associated with the exclusion of pUL27 from nucleoli during human cytomegalovirus infection.
    Hakki M; Drummond C; Houser B; Marousek G; Chou S
    Antiviral Res; 2011 Nov; 92(2):313-8. PubMed ID: 21906628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human cytomegalovirus UL97 kinase alters the accumulation of CDK1.
    Gill RB; James SH; Prichard MN
    J Gen Virol; 2012 Aug; 93(Pt 8):1743-1755. PubMed ID: 22552942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human cytomegalovirus UL97 kinase and nonkinase functions mediate viral cytoplasmic secondary envelopment.
    Goldberg MD; Honigman A; Weinstein J; Chou S; Taraboulos A; Rouvinski A; Shinder V; Wolf DG
    J Virol; 2011 Apr; 85(7):3375-84. PubMed ID: 21248036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of effects of inhibitors of viral and cellular protein kinases on human cytomegalovirus disruption of nuclear lamina and nuclear egress.
    Sharma M; Coen DM
    J Virol; 2014 Sep; 88(18):10982-5. PubMed ID: 24965476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human cytomegalovirus UL97 Kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis.
    Prichard MN; Britt WJ; Daily SL; Hartline CB; Kern ER
    J Virol; 2005 Dec; 79(24):15494-502. PubMed ID: 16306620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of the structure-activity relationship of four herpesviral UL97 subfamily protein kinases reveals partial but not full functional conservation.
    Romaker D; Schregel V; Maurer K; Auerochs S; Marzi A; Sticht H; Marschall M
    J Med Chem; 2006 Nov; 49(24):7044-53. PubMed ID: 17125257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir.
    Chou S; Waldemer RH; Senters AE; Michels KS; Kemble GW; Miner RC; Drew WL
    J Infect Dis; 2002 Jan; 185(2):162-9. PubMed ID: 11807689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of newly detected, drug-related HCMV UL97- and UL54-mutations using a modified plaque reduction assay.
    Fischer L; Sampaio KL; Jahn G; Hamprecht K; Göhring K
    J Clin Virol; 2015 Aug; 69():150-5. PubMed ID: 26209398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity.
    Herget T; Freitag M; Morbitzer M; Kupfer R; Stamminger T; Marschall M
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4154-62. PubMed ID: 15504835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human cytomegalovirus protein kinase UL97 forms a complex with the tegument phosphoprotein pp65.
    Kamil JP; Coen DM
    J Virol; 2007 Oct; 81(19):10659-68. PubMed ID: 17634236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation.
    Maertens J; Cordonnier C; Jaksch P; Poiré X; Uknis M; Wu J; Wijatyk A; Saliba F; Witzke O; Villano S
    N Engl J Med; 2019 Sep; 381(12):1136-1147. PubMed ID: 31532960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison between human cytomegalovirus pUL97 and murine cytomegalovirus (MCMV) pM97 expressed by MCMV and vaccinia virus: pM97 does not confer ganciclovir sensitivity.
    Wagner M; Michel D; Schaarschmidt P; Vaida B; Jonjic S; Messerle M; Mertens T; Koszinowski U
    J Virol; 2000 Nov; 74(22):10729-36. PubMed ID: 11044117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein.
    Talarico CL; Burnette TC; Miller WH; Smith SL; Davis MG; Stanat SC; Ng TI; He Z; Coen DM; Roizman B; Biron KK
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1941-6. PubMed ID: 10428917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of human cytomegalovirus (HCMV) UL97 mutations found in a valganciclovir/oral ganciclovir prophylactic trial by use of a bacterial artificial chromosome containing the HCMV genome.
    Martin M; Gilbert C; Covington E; Boivin G
    J Infect Dis; 2006 Sep; 194(5):579-83. PubMed ID: 16897654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maribavir use in practice for cytomegalovirus infection in French transplantation centers.
    Alain S; Revest M; Veyer D; Essig M; Rerolles JP; Rawlinson W; Mengelle C; Huynh A; Kamar N; Garrigue I; Kaminski H; Segard C; Presne C; Mazeron MC; Avettant-Fenoël V; Lecuit M; Lortholary O; Coaquette A; Hantz S; Leruez-Ville M; Ploy MC
    Transplant Proc; 2013 May; 45(4):1603-7. PubMed ID: 23726629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.